TITLE

THE IPO 100

PUB. DATE
March 2004
SOURCE
Investment Dealers' Digest;3/29/2004, Vol. 70 Issue 13, p39
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
This article presents information on IPOs in the U.S. The IPO 100 Index measures the average price of the most recent 100 initial public offerings, excluding closed-end funds and unit offerings containing warrants in the U.S. market. For the week ended March 24, the index closed at 18.10%. The best performer was Kintera Inc., up $1.94 to close at $16.94. The worst performer was Lipman Electronic Engineering, down $3.51 to close at $44.73. In all 33 stocks were up while 59 were down. 66 of the Index 100 components beat the S&P 500.
ACCESSION #
12660577

 

Related Articles

  • Fund of funds performance data.  // Fund Strategy;11/28/2005, p34 

    The article focuses on the performance of various mutual funds. The Credit Suisse Multi Manager Cautious Managed fund has slipped from third to fourth, while over three years its ranking has dropped from second to fourth, according to Standard & Poor's. The Jupiter Merlin Income Portfolio has...

  • Stock Funds Resume Their Inflow. PAUL KATZEFF // Investors Business Daily;2/27/2015, pA11 

    The article reports on the performance of stock funds in the U.S. Topics discussed include several key indicators such as the rate of its inflow, outflow and the Standard and Poor's 500 Index, the performance of hybrid funds invested in both stocks and bonds and the bond fund inflow and outflow...

  • WALL ST./FINANCE.  // MondayMorning;3/21/2011, Vol. 18 Issue 11, p3 

    The article focuses on the performance of the stock market in the U.S. in March 2011. It mentions a rise in the MSCI World Index following a cease-fire in Libya and the Federal Reserve's approval for an increase in dividends by some banks, a retreat in the Japanese currency yen, and a decline in...

  • WALL ST./FINANCE.  // MondayMorning;11/14/2011, Vol. 19 Issue 41, p16 

    The article presents updates in the Wall St/finance sector. U.S. equities extended an early rally after consumer sentiment topped estimates in November and bolstered optimism before the holiday shopping season. Standard & Poor rebounded about 15% from a 13-month low on October 3, 2011 as...

  • WALL ST./FINANCE.  // MondayMorning;5/6/2013, Vol. 21 Issue 17, p4 

    The article offers updates on the U.S. stock exchange and the Standard & Poor's 500 Index. It notes that the S&P 500 climbed 2% to 1,614.42 for the week ending My 3, 2013. It talks about the 7.9% rise in the profit of Apple Inc. It also talks about the success fo Epizyme Inc. to register up to...

  • FW poll: Investors split on tech bubble outlook. Jackson, Gary // Fundweb;11/18/2013, p6 

    The article focuses on the results of the Fundweb (FW) poll which shows that the technology stocks could be in a bubble as investors are feared to have gotten too excited about these stocks. It mentions the results of the FE Analytics which show that Standard & Poor's (S&P) 500 Internet Software...

  • WALL ST./FINANCE.  // MondayMorning;7/21/2014, Vol. 22 Issue 27, p4 

    The article offers news briefs related to financial industry in the U.S. Stock markets in the U.S. has jumped on July 18, 2014 as shown by the increase of the Standard & Poor's 500 index by 1% to 1, 978.22. Sage Therapeutics Inc. has opened an initial public offering (IPO) at $27.00 in July...

  • WALL ST./FINANCE.  // MondayMorning;9/29/2014, Vol. 22 Issue 35, p4 

    The article presents information on recent developments related to U.S. stocks markets. U.S. stocks has rebounded recently with the Standard & Poor's 500 Index jumping the most in five weeks, the fastest since 2011. Exagen Diagnostics Inc. has registered up to 69 million dollars worth of common...

  • WALL ST./FINANCE.  // MondayMorning;11/17/2014, Vol. 22 Issue 42, p1 

    The article offers news briefs on finance on the U.S. healthcare industry in 2014. The Standard & Poor 500 index of the country increases to its 41st high for the existing year. Biotechnology firm Fibrogen Inc. develops an antibody and an oral anemia therapy for idiopathic pulmonary fibrosis....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics